Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Cohort profile: the Viral load Cohort North-East Lesotho (VICONEL) from 2016 to 2022 – cohort description, test volumes, predictors of viraemia, and the road ahead

View ORCID ProfileJennifer A. Brown, Lipontso Motaboli, View ORCID ProfileMalebanye Lerotholi, Maurus Kohler, Kathrin Hänggi, Moliehi Mokete, Makobefo G. Chakela, Mpho Kao, Mathebe Kopo, Moleboheng Mokebe, Bienvenu L. Nsakala, View ORCID ProfileBlaise Lukau, Irene Ayakaka, View ORCID ProfileAlain Amstutz, Jochen Ehmer, View ORCID ProfileThomas Klimkait, View ORCID ProfileTracy R. Glass, View ORCID ProfileJosephine Muhairwe, View ORCID ProfileFrédérique Chammartin, View ORCID ProfileNadine Tschumi, View ORCID ProfileNiklaus D. Labhardt
doi: https://doi.org/10.1101/2024.03.12.24304025
Jennifer A. Brown
1Division of Clinical Epidemiology, University Hospital Basel, Basel, Switzerland
2University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jennifer A. Brown
Lipontso Motaboli
3SolidarMed, Partnerships for Health, Maseru, Lesotho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malebanye Lerotholi
1Division of Clinical Epidemiology, University Hospital Basel, Basel, Switzerland
2University of Basel, Basel, Switzerland
4Ministry of Health, Maseru, Lesotho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Malebanye Lerotholi
Maurus Kohler
1Division of Clinical Epidemiology, University Hospital Basel, Basel, Switzerland
2University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathrin Hänggi
1Division of Clinical Epidemiology, University Hospital Basel, Basel, Switzerland
2University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moliehi Mokete
3SolidarMed, Partnerships for Health, Maseru, Lesotho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Makobefo G. Chakela
3SolidarMed, Partnerships for Health, Maseru, Lesotho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mpho Kao
3SolidarMed, Partnerships for Health, Maseru, Lesotho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathebe Kopo
3SolidarMed, Partnerships for Health, Maseru, Lesotho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moleboheng Mokebe
3SolidarMed, Partnerships for Health, Maseru, Lesotho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bienvenu L. Nsakala
3SolidarMed, Partnerships for Health, Maseru, Lesotho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Blaise Lukau
3SolidarMed, Partnerships for Health, Maseru, Lesotho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Blaise Lukau
Irene Ayakaka
3SolidarMed, Partnerships for Health, Maseru, Lesotho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain Amstutz
1Division of Clinical Epidemiology, University Hospital Basel, Basel, Switzerland
2University of Basel, Basel, Switzerland
5Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital and University of Oslo, Oslo, Norway
6Bristol Medical School, Population Health Sciences, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alain Amstutz
Jochen Ehmer
7SolidarMed, Partnerships for Health, Lucerne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Klimkait
2University of Basel, Basel, Switzerland
8Molecular Virology, Department of Biomedicine, University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas Klimkait
Tracy R. Glass
2University of Basel, Basel, Switzerland
9Department of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tracy R. Glass
Josephine Muhairwe
3SolidarMed, Partnerships for Health, Maseru, Lesotho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Josephine Muhairwe
Frédérique Chammartin
1Division of Clinical Epidemiology, University Hospital Basel, Basel, Switzerland
2University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Frédérique Chammartin
Nadine Tschumi
1Division of Clinical Epidemiology, University Hospital Basel, Basel, Switzerland
2University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nadine Tschumi
Niklaus D. Labhardt
1Division of Clinical Epidemiology, University Hospital Basel, Basel, Switzerland
2University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Niklaus D. Labhardt
  • For correspondence: niklaus.labhardt{at}usb.ch
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Purpose The prospective Viral load Cohort North-East Lesotho (VICONEL) aims to support clinical management and generate scientific evidence to inform HIV care. Specifically, VICONEL allows for monitoring of HIV treatment outcomes and health system performance, encompasses a biobank for further research with routinely collected blood plasma samples of consenting participants, and provides a valuable framework for nested observational and interventional studies.

Participants VICONEL captures routine viral load test results alongside associated demographic and treatment information among people in care for HIV in Lesotho, southern Africa. As of December 2022, it encompasses all viral load testing from 23 healthcare facilities in two districts of Lesotho.

Findings to date From January 2016 to December 2022, 114’838 viral load test results were available for 27,472 participants. At the time of the last viral load test, median age was 42 years (interquartile range [IQR]: 33-53); 17,324 (63%) were adult women, 9,273 (34%) adult men, and 870 (3%) children <15 years (age/sex missing for 5); and median time taking antiretroviral therapy (ART) was 6.0 years (IQR 3.0-9.2). Overall, the proportion of cohort participants with viral suppression to <1,000 copies/mL has continually exceeded 90% and has been above 95% since 2020; however, this proportion has consistently been lower among children. Sex, age category / ART regimen core agent (combined variable), time since ART initiation, and district were independently associated with viraemia.

Future plans VICONEL offers potential for i) further digitalisation and automation of results sharing at the client, facility, and district/national level, ii) integration of additional clinical and diagnostic data, including HIV comorbidities, and iii) embedding randomised trials.

Strengths and limitations

  • - VICONEL covers all HIV viral load testing from 23 clinics in two districts in Lesotho and is thus highly representative.

  • - Data capture occurs at the time point of viral load testing; thus, treatment or clinical data are not updated between viral load tests, and reasons for exiting the cohort are not followed up.

  • - Participant data beyond viral load results are limited to key demographic, clinical, and treatment information.

  • - The cohort and associated biobank have proven to be a valuable platform for nested observational and interventional research, including randomised trials.

  • - Core functions can be maintained at low cost, constituting a model for near-real-time monitoring of treatment outcomes with limited resources.

Competing Interest Statement

NDL reports having received travel grants to attend IAS, AIDS, and CROI conferences from Gilead Sciences Sarl and ViiV Healthcare. All other authors declare that they have no competing interests.

Funding Statement

This study was funded by the Swiss National Science Foundation (IZ07Z0_160876/1, obtained by NDL; PCEFP3_181355, obtained by NDL) and ESTHER Switzerland (acquired by NDL). JAB receives her salary through grants from Fondation Botnar (REG-19-008, obtained by NDL and JAB) and the University of Basel Research Fund Junior Researchers (3ZX1422, acquired quired by JAB).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The National Health Research Ethics Committee in Lesotho has approved the cohort study (ID 134-2016) and waived consent for analyses using routine data. A biobank consent form for the further use of plasma left over after viral load testing is periodically offered at several sites. Several studies nested within VICONEL but involving non-routine procedures have required a separate study protocol and separate informed consent; data from such studies is not analysed here except insofar as it consists of additional viral load testing or overlaps with routinely collected data.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

Aggregated or de-identified individual patient data can be shared upon reasonable request and signing of a data sharing agreement. Investigators must submit a concept sheet detailing the required data and planned analyses to the corresponding author for internal review and approval. Publications arising from VICONEL data are subject to written approval by the Sponsor/Chief Investigator and/or the Principal Investigator. VICONEL investigators or contributors shall be co-authors on publications using VICONEL data, provided they fulfil authorship criteria as defined by the International Committee of Medical Journal Editors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted March 14, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Cohort profile: the Viral load Cohort North-East Lesotho (VICONEL) from 2016 to 2022 – cohort description, test volumes, predictors of viraemia, and the road ahead
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cohort profile: the Viral load Cohort North-East Lesotho (VICONEL) from 2016 to 2022 – cohort description, test volumes, predictors of viraemia, and the road ahead
Jennifer A. Brown, Lipontso Motaboli, Malebanye Lerotholi, Maurus Kohler, Kathrin Hänggi, Moliehi Mokete, Makobefo G. Chakela, Mpho Kao, Mathebe Kopo, Moleboheng Mokebe, Bienvenu L. Nsakala, Blaise Lukau, Irene Ayakaka, Alain Amstutz, Jochen Ehmer, Thomas Klimkait, Tracy R. Glass, Josephine Muhairwe, Frédérique Chammartin, Nadine Tschumi, Niklaus D. Labhardt
medRxiv 2024.03.12.24304025; doi: https://doi.org/10.1101/2024.03.12.24304025
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Cohort profile: the Viral load Cohort North-East Lesotho (VICONEL) from 2016 to 2022 – cohort description, test volumes, predictors of viraemia, and the road ahead
Jennifer A. Brown, Lipontso Motaboli, Malebanye Lerotholi, Maurus Kohler, Kathrin Hänggi, Moliehi Mokete, Makobefo G. Chakela, Mpho Kao, Mathebe Kopo, Moleboheng Mokebe, Bienvenu L. Nsakala, Blaise Lukau, Irene Ayakaka, Alain Amstutz, Jochen Ehmer, Thomas Klimkait, Tracy R. Glass, Josephine Muhairwe, Frédérique Chammartin, Nadine Tschumi, Niklaus D. Labhardt
medRxiv 2024.03.12.24304025; doi: https://doi.org/10.1101/2024.03.12.24304025

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • HIV/AIDS
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)